Circ_0051079 regulated OS development by the miR-625-5p/TRIM66/Wnt/beta-catenin pathway, providing a novel therapeutic target for OS.
Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/beta-catenin pathway in a miR-625-5p-dependent manner.